Fundz

IMUNON

Lawrenceville, New Jersey, United States · Biotechnology, Healthcare

IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality

Key facts

Headquarters
Lawrenceville, New Jersey, United States
Employees
24
Industries
Biotechnology, Healthcare
Status
Public (IMNN)
Website
imunon.com
LinkedIn
Company page

Recent activity at IMUNON

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

IMUNON funding history

DateRoundAmount
May 2025Seed$3.3M
Aug 2024Venture$10.0M
Jun 2015Venture$5.1M

Leadership

  • Johan Lindborg, BD Consultant
  • Michael Tardugno, Chairman
  • Douglas V. Faller, Chief Medical Officer
  • Stacy Lindborg, President

Verified email and direct lines for IMUNON’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

IMUNON files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Companies similar to IMUNON

About IMUNON: questions and answers

What does IMUNON do?

IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality

Where is IMUNON headquartered?

IMUNON is headquartered in Lawrenceville, New Jersey, United States.

How many employees does IMUNON have?

IMUNON has about 24 employees.

Has IMUNON raised funding?

Yes. Fundz has recorded 3 funding events for IMUNON. The most recent, Seed of $3.3M, was in May 2025.

Who leads IMUNON?

Stacy Lindborg is a President at IMUNON.

What is the latest news on IMUNON?

On May 27, 2025, IMUNON

Is IMUNON a public company?

Yes. IMUNON is publicly traded under the ticker IMNN.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches IMUNON across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.